Following the decriminalization of psilocybin-containing mushrooms (“magic mushrooms”) by Denver voters in May, Sträva has begun exploring the benefits and risks of combining micro-doses of psilocybin with their specialty coffees, including CBD-infused coffees.
“Just as cannabis has been misunderstood and controversial for decades, psilocybin from mushrooms has been equally polarizing, yet proponents of both suggest they each can contribute meaningfully to the human experience,” said Sträva CEO Andrew Aamot. “As research is proving, with measured consumption, cannabis and psilocybin can both promote physiological, mental and spiritual health.”
Psilocybin is naturally occurring in over 180 species of mushrooms. It stimulates serotonin receptors in the brain and is believed to expand neural activity. Traditional medicine and cultural rituals have embraced mushrooms for centuries for this reason; modern science is now offering validation. A 2013 study conducted by the University of South Florida showed that psilocybin acted to stimulate growth of new brain cells, while a 2014 study published in The Journal of Royal Society Interface demonstrated increased neural connectivity in the brain.
Designated by the FDA as a “breakthrough therapy,” the study of psilocybin for treatment of anxiety, addiction and resistant depression, is gaining traction. 2006 and 2011 studies by the University of Arizona showed “promising trends toward decreased psychological distress” using low-moderate (14mg/70kg) and (10mg, 25mg/70kg) doses.
By incorporating micro-doses of psilocybin into coffee and tea, Sträva aims to empower consumers with access to natural compounds which may offer life-changing benefits.